首届中国国际生物制药研讨会召开(4)
核心摘要:
L3 LiuFanglei ComparationofImmunogenicityinMiceofDifferentNeisseriaMeningococcalSerogroupAPolysaccharide-ProteinConjugateVaccines L4 LiuHongyan TheExpressionofHPV16/18L1inthePiehiaPastorisandPreparati
L3
Liu Fanglei
Comparation of Immunogenicity in Mice of Different Neisseria Meningococcal Serogroup A Polysaccharide-Protein Conjugate Vaccines
L4
Liu Hongyan
The Expression of HPV16/18L1 in the Piehia Pastoris and Preparation of the Antibodies
L5
Pan Shunan
Verification of Elisa Method on Detecting Residual Bovine Serum Contents in Viral Vaccines
P1
Peng Xiangbing
Cloning and Expression of Hcv C-Ns3 Chimeric Gene by Soe-Pcr
P2
Qu Aidong
The Study on the Site-Mutants of Diphtheria Toxin and Its Expression in E.Coli
Q1
Reza Afshari
Defining Illicit Pharmaceutical Market in 21st Century
R1
Samad Radjai
Successful Replacement of Serum by Plant Protein Hydrolysates in Cell Culture Media
S1
Shi Wei
Secreting Expression of Thymusin Alpha 1 in Pichia System
S2
Tan Changyao
Preparation and Immunogenicity of A Picha Pastoris-Derived Hepatitis B Vaccine Containing Pres1, Pres2 And S Epitopes
T1
Tian Shenghe
Apoptosis Effect of Recombinant Strail on Human Leukaemia K562 Cell Line
T2
Vincent GANNE
Montanide ISA 720 and 51: A New Generation of Water in Oil Emulsions as Adjuvants for Human Vaccines
V1
Wang Hui
Study on Production Technology and Quality Ensure of Vero Cell-Derived Inactivated Japanese Encephalitis Vaccine
W1
Wei-fen Li
Oral Vaccine Delivery System of Lactococcus Lactis and Its Improvements
W2
Weixing Chen
Breakthrough Technology for Large-Scale Protein Production with Transient Transfection Using CHO Suspension Cultures
W3
Willy W.L. Hong
RNA Silencing to Dihydrofolate Reductase Genes for Stable Producer Chinese Hamster Ovary Cells in Gene Amplification Process by A Stepwise Methotrexate Selection
W4
Xu Fanhong
Construction and Expression of Human G-CSF and FLT3 Ligand Fusion Protein in E.coli
X1
Xu Xiangtian
The Advance on Study and Applied on the Hepatitis B Therapeutic Vaccines
X2
Ying Lian-fang
Fermentation and Purification for the Recombinant Of HEV
Y1
Zhang Guoqiang
Study and Confirmation of Quantitative ELISA Kit for the Detection of Ovalbumin
Z1
Zhang Nan
Preparation and Characterization of Monoclonal Antibodies against Sars-Associated Coronavirus
Z2
Zhang Ping
Preparation of a Conjugate Vaccine Composed of Pneumococcus Type 14 Capsular Polysaccharide Bound to TT
Z3
Zhang Zhenlong
Construction,Expression and Activity Analysis of Recombinant Human Ciliary Neurotrophic Factor Derivative
Z4
Zhang Zhizhou
Modernization of Chinese Medicine is Facing Threat in Systems Biology Era
Z5
Zhao Hong
The Efficiency of the Mouse Model for Evaluating Toxin-Neutralization in Vitro and Protection in Vivo of Anti-Tetanus Human Monoclonal Antibodies
Z6
Zheng Xinxiong
Safety and Efficacy Test of Freeze-Drying Purified Human Rabies Vaccine Manufactured by Wibp
Z7
前言
为了促进我国生物医药技术的发展,认真分析与国际同行间存在的优势与差距,切实加强国际间的交流与合作,提高对生物医药市场的开发、引导和监督管理能力,由中国药学会、美国巴特尔科学技术研究院和中国生化制药工业协会共同发起的首届中国国际生物制药研讨会将在北京召开。此次会议我们将组织来自美国、欧盟、中东和亚太地区的中小型生物医药企业、与生物医药相关的工业、政府和科研机构的专家学者参加会议,围绕疫苗、抗体和基因治疗药物所涉及的科研、生产、监管、法规与知识产权保护、国际贸易等话题,通过大会报告、壁报交流、企业展示等方式,本着认真、求实、学习、解决问题的态度,为与会代表搭建一个进行广泛、深入、富有成效的交流平台,使国内参会者全面了解全球生物医药技术与市场的发展动态并为国内生物医药企业创造全球合作机会。
国际执行委员会
Dr. Mason Soule, Battelle, USA
刘春光,中国药学会,中国
Dr. Richard M. Price, ASA, USA
Dr. Steve Bice, Battelle, USA
Dr. Mick Garstang, Acambis plc, UK
论文评审委员会
Dr. David Robinson, Battelle, USA
Dr. Barbara B. S. Price,ASA, USA
Dr. James Estep, Battelle, USA
Dr. Mohammed Al-Ahdal, SFDA, Saudi Arabia
Dr. Ben Prickril, BioVision, France
上一篇:我国生物制药下游技术差距较大
下一篇:我国生物医药技术仍需加大创新力度